Aims: We aimed to describe cases with incidental neuropathological findings of progressive supranuclear palsy (PSP) from the Banner Sun Health Research Institute Brain and Body Donation Program. Methods: We performed a retrospective review of 277 subjects with longitudinal motor and neuropsychological assessments who came to autopsy. The mean Gallyas-positive PSP features grading for subjects with possible incidental neuropathological PSP was compared to those of subjects with clinically manifest disease. Results: There were 5 cases with histopathological findings suggestive of PSP, but no parkinsonism, dementia or movement disorder during life. Cognitive evaluation revealed 4 of the 5 cases to be cognitively normal; one case had amnestic m...
OBJECTIVE: Clinicopathological studies over the last decade have broadened the clinical spectrum of ...
Although similar cases were described without pathologic correlation, progressive supranuclear palsy...
Introduction: Movement Disorder Society (MDS) new diagnostic criteria for Progressive Supranuclear p...
BACKGROUND: Progressive supranuclear palsy (PSP) is a neuropathologically defined disease presenting...
Background: The influence of concomitant brain pathologies on the progression rate in PSP is unclear...
INTRODUCTION: Supranuclear gaze palsy (SGP) is a classic clinical feature of progressive supranuclea...
Patients with progressive supranuclear palsy (PSP) often develop dementia, and cortical pathology ha...
BackgroundProgressive supranuclear palsy (PSP) is a neurodegenerative disorder characterized by neur...
Background: PSP is a neuropathologically defined disease entity. Clinical diagnostic criteria, publi...
The pathologic changes of Parkinson's disease (PD) and Progressive Supranuclear Palsy (PSP) have bee...
Progressive supranuclear palsy (PSP) is a distinctive form of neurodegenerative disease which affect...
BACKGROUND: PSP is a neuropathologically defined disease entity. Clinical diagnostic criteria, publi...
Background: PSP is a neuropathologically defined disease entity. Clinical diagnostic criteria, publi...
Background: PSP is a neuropathologically defined disease entity. Clinical diagnostic criteria, publi...
Background: PSP is a neuropathologically defined disease entity. Clinical diagnostic criteria, publi...
OBJECTIVE: Clinicopathological studies over the last decade have broadened the clinical spectrum of ...
Although similar cases were described without pathologic correlation, progressive supranuclear palsy...
Introduction: Movement Disorder Society (MDS) new diagnostic criteria for Progressive Supranuclear p...
BACKGROUND: Progressive supranuclear palsy (PSP) is a neuropathologically defined disease presenting...
Background: The influence of concomitant brain pathologies on the progression rate in PSP is unclear...
INTRODUCTION: Supranuclear gaze palsy (SGP) is a classic clinical feature of progressive supranuclea...
Patients with progressive supranuclear palsy (PSP) often develop dementia, and cortical pathology ha...
BackgroundProgressive supranuclear palsy (PSP) is a neurodegenerative disorder characterized by neur...
Background: PSP is a neuropathologically defined disease entity. Clinical diagnostic criteria, publi...
The pathologic changes of Parkinson's disease (PD) and Progressive Supranuclear Palsy (PSP) have bee...
Progressive supranuclear palsy (PSP) is a distinctive form of neurodegenerative disease which affect...
BACKGROUND: PSP is a neuropathologically defined disease entity. Clinical diagnostic criteria, publi...
Background: PSP is a neuropathologically defined disease entity. Clinical diagnostic criteria, publi...
Background: PSP is a neuropathologically defined disease entity. Clinical diagnostic criteria, publi...
Background: PSP is a neuropathologically defined disease entity. Clinical diagnostic criteria, publi...
OBJECTIVE: Clinicopathological studies over the last decade have broadened the clinical spectrum of ...
Although similar cases were described without pathologic correlation, progressive supranuclear palsy...
Introduction: Movement Disorder Society (MDS) new diagnostic criteria for Progressive Supranuclear p...